Walgreens Boots Alliance Inc (WBA)

[big-yank]

What the DEA has been tracking is abnormal activity, huge quantities flowing through retail distribution, that should have red-flagged potential abuse of controlled substances. This is a corporate issue, not a pharmacist issue, although in the CVS example two individual pharmacies were cited for excessive volume in oxycontin and oxycodone. Normally I would expect that the Loss Prevention Department would have the responsibility to identify and investigate abnormalities in this area.

A pharmacist's sole responsibility in dispensing such medications would be identifying potential interaction problems, or perhaps calling the MD that wrote the script to question an extremely high dosage.